Status:
NOT_YET_RECRUITING
Evaluation of Atherectomy in the Management of Occlusive Lesions of the Common Femoral Arteries
Lead Sponsor:
Ramsay Générale de Santé
Conditions:
Femoral Artery Occlusion
Atheromatous Plaques
Eligibility:
All Genders
18+ years
Brief Summary
Thromboendarterectomy is the standard technique for the treatment of symptomatic occlusive lesions of the common femoral artery. It consists of surgically controlling the artery and interrupting circu...
Eligibility Criteria
Inclusion
- Male or female patient over 18 years of age
- Non-emergency
- Claudicating patient with significant de novo calcified stenosis affecting the common femoral artery, technically eligible for revascularization by thromboendarterectomy or rotational atherectomy
- Surgery planned with either technique
- Patient's consent to participate in the study must be obtained,
Exclusion
- Patient contraindicated for either technique (for surgical or anesthesiological reasons)
- Patient with asymptomatic lesions of the common femoral artery
- Patient with a history of surgery or angioplasty/stenting of the femoral stump
- Patient with occlusion of the ipsilateral common femoral artery or external iliac artery
- Patient with an indication for additional aortofemoral, iliofemoral, femoral-popliteal, or hamstring bypass
- Patient with severe trophic disorders for which a major amputation is considered immediately in addition to revascularization
- Patient objecting to the use of their data
Key Trial Info
Start Date :
September 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT07142330
Start Date
September 1 2025
End Date
September 1 2026
Last Update
August 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Privé de Villeneuve d'Ascq,
Villeneuve-d'Ascq, France, 59650